Pulmatrix, Inc. (NasdaqCM:PULM) has retained MTS Health Partners, L.P. (MTS) as its financial advisor to support the company's Board of Directors and management team to review and evaluate strategic alternatives intended to maximize long-term value for all stockholders.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.9 USD | -6.86% | -5.71% | +2.15% |
Mar. 28 | Pulmatrix, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 13 | Pulmatrix, Inc. Approves Termination of Margaret Wasilewski as Chief Medical Officer | CI |
1st Jan change | Capi. | |
---|---|---|
+2.15% | 7.45M | |
-2.63% | 103B | |
+1.62% | 95.28B | |
+1.46% | 22.15B | |
-16.67% | 21.02B | |
-8.58% | 18.15B | |
-38.74% | 16.73B | |
-13.21% | 16.05B | |
+5.41% | 13.68B | |
+33.57% | 12.17B |
- Stock Market
- Equities
- PULM Stock
- News Pulmatrix, Inc.
- Pulmatrix Explores Strategic Alternatives